Clinical Trial Update: To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating efficacy and safety in patients with primary hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: JW Pharmaceutical | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: COMPLETED